{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:54:18Z","timestamp":1783385658758,"version":"3.54.6"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,25]]},"DOI":"10.7759\/cureus.100058","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T13:16:14Z","timestamp":1766668574000},"source":"Crossref","is-referenced-by-count":1,"title":["Improving Helicobacter pylori Treatment Standards: A Quality Improvement Project Against Maastricht VI Guidelines"],"prefix":"10.7759","author":[{"given":"Siddharth","family":"Varier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mansingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavi","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yash M","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed  A","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global Prevalence of Helicobacter pylori Infection: systematic review and meta-analysis","volume":"153","author":"Hooi JK","year":"2017","unstructured":"Hooi JK, Lai WY, Ng WK, et al.. Global Prevalence of Helicobacter pylori Infection: systematic review and meta-analysis. Gastroenterology. 2017, 153:420-9. 10.1053\/j.gastro.2017.04.022","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.54743","article-title":"Helicobacter pylori infection in developing countries: the burden for how long?","volume":"15","author":"Salih BA","year":"2009","unstructured":"Salih BA. Helicobacter pylori infection in developing countries: the burden for how long?. Saudi J Gastroenterol. 2009, 15:201-7. 10.4103\/1319-3767.54743","journal-title":"Saudi J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2008.02.026","article-title":"Helicobacter pylori infection: a clinical overview","volume":"40","author":"Kandulski A","year":"2008","unstructured":"Kandulski A, Selgrad M, Malfertheiner P. Helicobacter pylori infection: a clinical overview. Dig Liver Dis. 2008, 40:619-26. 10.1016\/j.dld.2008.02.026","journal-title":"Dig Liver Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000538349","article-title":"Diagnostic methods for Helicobacter pylori","volume":"33","author":"Costa LC","year":"2024","unstructured":"Costa LC, das Gra\u00e7as Carvalho M, La Gu\u00e1rdia Cust\u00f3dio Pereira AC, Teixeira Neto RG, Andrade Figueiredo LC, Barros-Pinheiro M. Diagnostic methods for Helicobacter pylori. Med Princ Pract. 2024, 33:173-84. 10.1159\/000538349","journal-title":"Med Princ Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","volume":"71","author":"Malfertheiner P","year":"2022","unstructured":"Malfertheiner P, Megraud F, Rokkas T, et al.. Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report. Gut. 2022, 71:1724-62. 10.1136\/gutjnl-2022-327745","journal-title":"Gut"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36041","article-title":"From antibiotic resistance to antibiotic renaissance: a new era in Helicobacter pylori treatment","volume":"15","author":"Godavarthy PK","year":"2023","unstructured":"Godavarthy PK, Puli C. From antibiotic resistance to antibiotic renaissance: a new era in Helicobacter pylori treatment. Cureus. 2023, 15:e36041. 10.7759\/cureus.36041","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i31.5152","article-title":"Helicobacter pylori eradication: exploring its impacts on the gastric mucosa","volume":"27","author":"Weng CY","year":"2021","unstructured":"Weng CY, Xu JL, Sun SP, Wang KJ, Lv B. Helicobacter pylori eradication: exploring its impacts on the gastric mucosa. World J Gastroenterol. 2021, 27:5152-70. 10.3748\/wjg.v27.i31.5152","journal-title":"World J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320839","article-title":"Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis","volume":"69","author":"Ford AC","year":"2020","unstructured":"Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut. 2020, 69:2113-21. 10.1136\/gutjnl-2020-320839","journal-title":"Gut"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72400-0","article-title":"Clinical factors associated with initial Helicobacter pylori eradication therapy: a retrospective study in China","volume":"10","author":"Tang Y","year":"2020","unstructured":"Tang Y, Tang G, Pan L, Zhu H, Zhou S, Wei Z. Clinical factors associated with initial Helicobacter pylori eradication therapy: a retrospective study in China. Sci Rep. 2020, 10:15403. 10.1038\/s41598-020-72400-0","journal-title":"Sci Rep"},{"key":"ref10","article-title":"Eradication rate of Helicobacter pylori using a two-week quadruple therapy: a report from southern Iran","volume":"5","author":"Masoodi M","year":"2013","unstructured":"Masoodi M, Panahian M, Rezadoost A, Heidari A. Eradication rate of Helicobacter pylori using a two-week quadruple therapy: a report from southern Iran. Middle East J Dig Dis. 2013, 5:81-5.","journal-title":"Middle East J Dig Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1042070","article-title":"Current and future perspectives for Helicobacter pylori treatment and management: from antibiotics to probiotics","volume":"12","author":"Liang B","year":"2022","unstructured":"Liang B, Yuan Y, Peng XJ, Liu XL, Hu XK, Xing DM. Current and future perspectives for Helicobacter pylori treatment and management: from antibiotics to probiotics. Front Cell Infect Microbiol. 2022, 12:1042070. 10.3389\/fcimb.2022.1042070","journal-title":"Front Cell Infect Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-02707-5","article-title":"Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis","volume":"23","author":"Fekadu S","year":"2023","unstructured":"Fekadu S, Engiso H, Seyfe S, Iizasa H, Godebo A, Deyno S, Yoshiyama H. Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis. BMC Gastroenterol. 2023, 23:55. 10.1186\/s12876-023-02707-5","journal-title":"BMC Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham DY","year":"2010","unstructured":"Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010, 59:1143-53. 10.1136\/gut.2009.192757","journal-title":"Gut"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-025-00744-x","article-title":"Analysis of antimicrobial resistance patterns and genetic mutations in\u00a0Helicobacter pylori\u00a0from\u00a0West Bengal, India depicting escalating clarithromycin and high levofloxacin resistance","volume":"17","author":"Paul S","year":"2025","unstructured":"Paul S, Karmakar BC, Roy N, Chaudhuri S, Mukhopadhyay AK. Analysis of antimicrobial resistance patterns and genetic mutations in\u00a0Helicobacter pylori\u00a0from\u00a0West Bengal, India depicting escalating clarithromycin and high levofloxacin resistance. Gut Pathog. 2025, 17:71. 10.1186\/s13099-025-00744-x","journal-title":"Gut Pathog"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v89i8-S.7910","article-title":"Non-invasive tests for the diagnosis of helicobacter pylori: state of the art","volume":"89","author":"Stefano K","year":"2018","unstructured":"Stefano K, Rosalia A, Chiara B, et al.. Non-invasive tests for the diagnosis of helicobacter pylori: state of the art. Acta Biomed. 2018, 89:58-64. 10.23750\/abm.v89i8-S.7910","journal-title":"Acta Biomed"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2021105","article-title":"Clinical audit of current Helicobacter pylori treatment outcomes in Singapore","volume":"63","author":"Ang TL","year":"2022","unstructured":"Ang TL, Lim KW, Ang D, Wong YJ, Tan M, Yih Wong AS. Clinical audit of current Helicobacter pylori treatment outcomes in Singapore. Singapore Med J. 2022, 63:503-8. 10.11622\/smedj.2021105","journal-title":"Singapore Med J"},{"key":"ref17","article-title":"Efficacy of clarithromycin containing bismuth-based regimen as a second-line therapy in Helicobacter pylori eradication","volume":"7","author":"Mokhtare M","year":"2015","unstructured":"Mokhtare M, Agah S, Fakheri H, Hosseini V, Rezaei Hemami M, Ghafoori SM. Efficacy of clarithromycin containing bismuth-based regimen as a second-line therapy in Helicobacter pylori eradication . Middle East J Dig Dis. 2015, 7:75-81.","journal-title":"Middle East J Dig Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001175.pub4","article-title":"Computer\u2010generated reminders delivered on paper to healthcare professionals: effects on professional practice and healthcare outcomes","volume":"2017","author":"Arditi C","year":"2017","unstructured":"Arditi C, R\u00e8ge\u2010Walther M, Durieux P, Burnand B. Computer\u2010generated reminders delivered on paper to healthcare professionals: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2017, 2017:CD001175. 10.1002\/14651858.CD001175.pub4","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/446874-improving-helicobacter-pylori-treatment-standards-a-quality-improvement-project-against-maastricht-vi-guidelines","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T13:16:15Z","timestamp":1766668575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/446874-improving-helicobacter-pylori-treatment-standards-a-quality-improvement-project-against-maastricht-vi-guidelines"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.100058","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,25]]}}}